Evidence map›Paper›PMID 32724464›Full record

ArticleTheranostics2020

Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates.

Liu Xu, Yutong Wang, Chenqi Zhu, Shujing Ren, Yurou Shao, Li Wu, Weidong Li, Xiaobin Jia, Rongfeng Hu, Rui Chen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Nanofiber Carriers of Therapeutic Load: Current Trends.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Liu XuCollege of pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Yutong WangCollege of pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Chenqi ZhuCollege of pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Shujing RenCollege of pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Yurou ShaoCollege of pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Li WuCollege of pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Weidong LiCollege of pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Xiaobin JiaSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Rongfeng HuKey Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui 230038, People's Republic of China.
Rui ChenCollege of pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Zhipeng ChenCollege of pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Nanjing University of Chinese Medicine · CNChina Pharmaceutical University · CNSuzhou Municipal Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCell Line, TumorDisease Models, AnimalDoxorubicinDrug CarriersDrug LiberationDrug StabilityHumansHydrogen-Ion ConcentrationMiceNanoparticlesNeoplasmsParticle SizePeptidesPolylysineTandem Mass SpectrometryDoxorubicinDrug CarriersPeptidesPolylysineacid-responsiveintravenous nanomedicinelong retention, peptide-drug conjugatesmorphology transformation

Identifiers

PMID32724464
PMCPMC7381745
OpenAlexW3044587683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.